Castle Biosciences, Inc. (CSTL) Revenue History
Castle Biosciences, Inc. (CSTL) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2019-12-31 | $51.87M |
| 2020-12-31 | $62.65M |
| 2021-12-31 | $94.08M |
| 2022-12-31 | $137.04M |
| 2023-12-31 | $219.79M |
| 2024-12-31 | $332.07M |
| 2025-12-31 | $344.23M |
How CSTL compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| KRYS | Krystal Biotech Inc. | $389.13M |
| MNKD | MannKind Corporation | $348.97M |
| FLGT | Fulgent Genetics Inc. | $322.67M |
| EOLS | Evolus Inc. | $297.18M |
| RIGL | Rigel Pharmaceuticals Inc. | $294.28M |
These are five companies in the same sector as CSTL with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Castle Biosciences, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CSTL", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CSTL | $30.55 | -2.80% | 0.36M |
| 3 | ||||
| 4 | ||||
| 5 |